These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 38650144)
1. Comprehensive bioinformatics analysis of KIF20A as a prognosis biomarker for clear cell renal cell carcinoma. Xie C; Yiu W; Mo Y Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):116-124. PubMed ID: 38650144 [TBL] [Abstract][Full Text] [Related]
2. ERBB2 is a potential diagnostic and prognostic biomarker in renal clear cell carcinoma. Gao WN; Chen LG; Bao LR; He N; Hu TL; Lai C; Xu RF; Wang XF; Wang JY; Zhao JR; Meng Y Sci Rep; 2024 Oct; 14(1):22775. PubMed ID: 39353993 [TBL] [Abstract][Full Text] [Related]
3. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis. Cui Y; Zhou Z; Chai Y; Zhang Y J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313 [TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma. Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694 [TBL] [Abstract][Full Text] [Related]
5. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma. Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243 [TBL] [Abstract][Full Text] [Related]
6. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma. Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis. Zhou L; Liu S; Li X; Yin M; Li S; Long H Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867 [TBL] [Abstract][Full Text] [Related]
8. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis. Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578 [TBL] [Abstract][Full Text] [Related]
9. Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241 [TBL] [Abstract][Full Text] [Related]
10. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics. Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501 [TBL] [Abstract][Full Text] [Related]
11. HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration. Zhang F; Yuan D; Song J; Chen W; Wang W; Zhu G; Hu B; Chen X; Zhu J Int Immunopharmacol; 2021 Oct; 99():107899. PubMed ID: 34217993 [TBL] [Abstract][Full Text] [Related]
12. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma. Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572 [TBL] [Abstract][Full Text] [Related]
13. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma. Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950 [TBL] [Abstract][Full Text] [Related]
14. A cluster of metabolism-related genes predict prognosis and progression of clear cell renal cell carcinoma. Liu M; Pan Q; Xiao R; Yu Y; Lu W; Wang L Sci Rep; 2020 Jul; 10(1):12949. PubMed ID: 32737333 [TBL] [Abstract][Full Text] [Related]
15. TEK is a novel prognostic marker for clear cell renal cell carcinoma. Ha M; Son YR; Kim J; Park SM; Hong CM; Choi D; Kang W; Kim JH; Lee KJ; Park D; Han ME; Oh SO; Lee D; Kim YH Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1451-1458. PubMed ID: 30840266 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of cyclin F/CCNF as an independent prognostic factor for poor survival in clear cell renal cell carcinoma. Kwiatkowski M; Krajewski A; Durślewicz J; Buchholz K; Grzanka D; Gagat M; Zabrzyński J; Klimaszewska-Wiśniewska A Sci Rep; 2024 Apr; 14(1):9280. PubMed ID: 38654021 [TBL] [Abstract][Full Text] [Related]
17. Identification of potential biomarkers for progression and prognosis of renal clear cell carcinoma by comprehensive bioinformatics analysis. Dong H; He Z; Wang H; Ding M; Huang Y; Li H; Shi H; Mao L; Hu C; Wang J Technol Health Care; 2024; 32(2):897-914. PubMed ID: 37483037 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma. Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310 [TBL] [Abstract][Full Text] [Related]
19. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma. Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227 [TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway. Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]